Strides Arcolab has now made a strategic investment in Oncobiologics
Inc, which is a privately held New Jersey-based biopharmaceutical firm
developing a pipeline of biosimilars and next generation
bio-therapeutics. The financial details have not been disclosed.
According to the Bengaluru-based Strides, the investment is part of its efforts to fund promising bio-pharma companies with high quality scientific management and proprietary approaches to developments that confer significant time and cost advantages.
“The investments by Strides
Arcolab represent important milestones for Oncobiologics. The company
is a long-term strategic partner that provides both financial strength
and a proven track-record of successful business ventures. We look
forward to their support and guidance as we continue to execute
Oncobiologics’ business and technical plans,” said Dr Pankaj Mohan,
Founder & CEO, Oncobiologics.
According to the Bengaluru-based Strides, the investment is part of its efforts to fund promising bio-pharma companies with high quality scientific management and proprietary approaches to developments that confer significant time and cost advantages.
“The investments by Strides
Arcolab represent important milestones for Oncobiologics. The company
is a long-term strategic partner that provides both financial strength
and a proven track-record of successful business ventures. We look
forward to their support and guidance as we continue to execute
Oncobiologics’ business and technical plans,” said Dr Pankaj Mohan,
Founder & CEO, Oncobiologics. 
No comments:
Post a Comment